Concert Pharmaceuticals Correlations

CNCEDelisted Stock  USD 8.37  0.01  0.12%   
The current 90-days correlation between Concert Pharmaceuticals and Weyco Group is 0.09 (i.e., Significant diversification). The correlation of Concert Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Concert Pharmaceuticals Correlation With Market

Modest diversification

The correlation between Concert Pharmaceuticals and DJI is 0.24 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Concert Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

Moving together with Concert Stock

  0.93SSNLF Samsung ElectronicsPairCorr
  0.89PTAIF PT Astra InternationalPairCorr
  0.73T ATT Inc Aggressive PushPairCorr
  0.69XOM Exxon Mobil Corp Sell-off TrendPairCorr
  0.78BAC Bank of America Aggressive PushPairCorr
  0.72INTC Intel Fiscal Year End 23rd of January 2025 PairCorr
  0.89AA Alcoa Corp Fiscal Year End 15th of January 2025 PairCorr
  0.73WMT Walmart Aggressive PushPairCorr
  0.76CAT Caterpillar Fiscal Year End 3rd of February 2025 PairCorr
  0.77TRV The Travelers Companies Fiscal Year End 17th of January 2025 PairCorr
  0.79AXP American Express Fiscal Year End 24th of January 2025 PairCorr
  0.71HD Home Depot Sell-off TrendPairCorr
  0.93CSCO Cisco Systems Aggressive PushPairCorr

Moving against Concert Stock

  0.91MRK Merck Company Fiscal Year End 6th of February 2025 PairCorr
  0.81TLK Telkom Indonesia TbkPairCorr
  0.81KO Coca Cola Sell-off TrendPairCorr
  0.77PPERF Bank Mandiri PerseroPairCorr
  0.77BKRKF PT Bank RakyatPairCorr
  0.75PPERY Bank Mandiri PerseroPairCorr
  0.59PFE Pfizer Inc Aggressive PushPairCorr
  0.42PTAIY Astra International TbkPairCorr
  0.4PBCRY Bank Central AsiaPairCorr
  0.34MMM 3M Company Fiscal Year End 28th of January 2025 PairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
PLYAWEYS
DINWEYS
PLYADIN
PLYASMIZF
PKWEYS
PKDIN
  
High negative correlations   
PLYAHPP
SMIZFHPP
HPPWEYS
HPPDIN
PKHPP
PKTOWTF

Risk-Adjusted Indicators

There is a big difference between Concert Stock performing well and Concert Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Concert Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Concert Pharmaceuticals Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Concert Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Concert Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Concert Pharmaceuticals by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Concert Pharmaceuticals Corporate Management

Justine KoenigsbergVP of Corporate Communications and Investor RelationsProfile
Nancy StuartChief OfficerProfile
Marc BeckerChief OfficerProfile
Jeffrey MunsieChief SecProfile
Nabil PharmDVP DevelProfile

Still Interested in Concert Pharmaceuticals?

Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.